Haemonetics HAE
NYSE HAE
$108.58 +0.17 (+0.16%)
At close: Aug 20, 2026 · 10:17 AM UTC

Haemonetics (HAE) Revenue Growth (5y) (2014 - 2026)

Haemonetics (HAE) Revenue Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.70 Bn 194.09 Bn 7.27 Bn
2 Stryker 129.93 Bn 126.46 Bn 4.50 Bn
3 Medtronic 120.49 Bn 111.27 Bn 6.41 Bn
4 Boston Scientific 74.60 Bn 74.06 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.42 Bn 1.35 Bn
6 Dexcom 34.78 Bn 32.84 Bn 830.00 Mn
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn
8 Koninklijke Philips 26.44 Bn 23.12 Bn 4.55 Bn
9 Steris 23.18 Bn 22.69 Bn 684.20 Mn
10 Haemonetics 4.93 Bn 4.70 Bn 202.80 Mn

Historic Data

Download Data
DateValue
Jun 27, 2026 8.23%
Mar 28, 2026 9.01%
Dec 27, 2025 7.12%
Sep 27, 2025 9.34%
Jun 28, 2025 10.44%
Mar 29, 2025 6.75%
Dec 28, 2024 6.12%
Sep 28, 2024 6.47%
Jun 29, 2024 7.11%
Mar 30, 2024 6.61%
Dec 30, 2023 6.33%
Sep 30, 2023 5.66%
Jul 1, 2023 6.30%
Apr 1, 2023 5.44%
Dec 31, 2022 5.46%
Oct 1, 2022 5.71%
Jul 2, 2022 4.39%
Apr 2, 2022 3.05%
Jan 1, 2022 2.66%
Oct 2, 2021 1.72%